Gabelli Funds’s Filana Therapeutics FLNA Stock Holding History

Gabelli Funds’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-23,571	Closed	-$98K	–	1129
2017 Q2	$98K	Sell	23,571 -1,429	-6%	-$6.75K	﹤0.01%	1116
2017 Q1	$156K	Hold	25,000	–	–	﹤0.01%	1107
2016 Q4	$100K	Buy	25,000 +2,143	+9%	+$9.94K	﹤0.01%	1125
2016 Q3	$160K	Hold	22,857	–	–	﹤0.01%	1132
2016 Q2	$350K	Hold	22,857	–	–	﹤0.01%	1071
2016 Q1	$357K	Hold	22,857	–	–	﹤0.01%	1044
2015 Q4	$280K	Hold	22,857	–	–	﹤0.01%	1061
2015 Q3	$293K	Sell	22,857 -714	-3%	-$9.01K	﹤0.01%	1006
2015 Q2	$285K	Hold	23,571	–	–	﹤0.01%	1027
2015 Q1	$312K	Sell	23,571 -1,429	-6%	-$19.3K	﹤0.01%	1011
2014 Q4	$355K	Sell	25,000 -714	-3%	-$12.4K	﹤0.01%	1014
2014 Q3	$704K	Sell	25,714 -12,143	-32%	-$369K	﹤0.01%	936
2014 Q2	$1.52M	Sell	37,857 -2,857	-7%	-$106K	0.01%	808
2014 Q1	$1.57M	Sell	40,714 -2,143	-5%	-$75.7K	0.01%	795
2013 Q4	$1.46M	Sell	42,857 -7,857	-15%	-$209K	0.01%	799
2013 Q3	$966K	Sell	50,714 -3,572	-7%	-$62.4K	0.01%	853
2013 Q2	$840K	Buy	+54,286	New	+$1.15M	0.01%	852

Other funds holding FLNA

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gabelli Funds's FLNA Position: Q3 2017 in Review

Gabelli Funds sold out of Filana Therapeutics (FLNA) in Q3 2017, closing a stake of 23,571 shares — an estimated $98K sold.

Gabelli Funds first reported a position in FLNA in Q2 2013 and held it in 17 quarters. The position peaked at $1.57M in Q1 2014. 28 funds tracked by Wall St. Rank hold FLNA as of Q3 2017.

Gabelli Funds reported no remaining Filana Therapeutics position as of Q3 2017 after selling out during the quarter.
Gabelli Funds sold 23,571 Filana Therapeutics shares in Q3 2017, an estimated $98K.
Gabelli Funds first reported a position in Filana Therapeutics in Q2 2013 and held it in 17 quarters.
Gabelli Funds's Filana Therapeutics position peaked at $1.57M in Q1 2014.
28 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2017.

Based on Gabelli Funds's 13F filing for Q3 2017, filed 1 Nov 2017.